Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;59(11):7153-5.
doi: 10.1128/AAC.01027-15. Epub 2015 Aug 31.

Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex

Aurélie Renvoisé  1 , Florence Brossier  1 , Eve Galati  2 , Nicolas Veziris  1 , Wladimir Sougakoff  1 , Alexandra Aubry  1 , Jérôme Robert  1 , Emmanuelle Cambau  3 , Vincent Jarlier  1 , Christine Bernard  4
Affiliations

Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex

Aurélie Renvoisé et al. Antimicrob Agents Chemother. 2015 Nov.
No abstract available

PubMed Disclaimer

Figures

FIG 1
FIG 1
Distribution of MAC isolates according to clarithromycin or amikacin MIC (mg/liter) determined by broth microdilution method. The cutoffs are symbolized by double-ended arrows. Distribution (percentage of isolates) of M. avium (a) and M. intracellulare (b) isolates according to clarithromycin MIC and of M. avium (c) and M. intracellulare (d) isolates according to amikacin MIC. Dark gray bars show data for strains isolated in patients with no history of antibiotic treatment, and light gray bars show data for strains isolated in patients with a history of antibiotic treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416. doi:10.1164/rccm.200604-571ST. - DOI - PubMed
    1. Brown-Elliott BA, Iakhiaeva E, Griffith DE, Woods GL, Stout JE, Wolfe CR, Turenne CY, Wallace RJ Jr. 2013. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol 51:3389–3394. doi:10.1128/JCM.01612-13. - DOI - PMC - PubMed
    1. Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E. 2011. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother 55:775–781. doi:10.1128/AAC.00861-10. - DOI - PMC - PubMed
    1. Renvoise A, Bernard C, Veziris N, Galati E, Jarlier V, Robert J. 2014. Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol 52:4439–4440. doi:10.1128/JCM.02127-14. - DOI - PMC - PubMed
    1. Jamal MA, Maeda S, Nakata N, Kai M, Fukuchi K, Kashiwabara Y. 2000. Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. Tuber Lung Dis 80:1–4. doi:10.1054/tuld.1999.0227. - DOI - PubMed

Publication types

MeSH terms